227 related articles for article (PubMed ID: 12446925)
1. Crooke's hyalinization in silent corticotroph adenoma: report of two cases.
Roncaroli F; Faustini-Fustini M; Mauri F; Asioli S; Frank G
Endocr Pathol; 2002; 13(3):245-9. PubMed ID: 12446925
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic correlations of silent corticotroph adenomas of the pituitary: report of four cases and literature review.
Sahli R; Christ ER; Seiler R; Kappeler A; Vajtai I
Pathol Res Pract; 2006; 202(6):457-64. PubMed ID: 16497445
[TBL] [Abstract][Full Text] [Related]
3. Massive Crooke's hyalinization in corticotroph cell adenomas of the human pituitary. A histological, immunocytological, and electron microscopic study of three cases.
Felix IA; Horvath E; Kovacs K
Acta Neurochir (Wien); 1981; 58(3-4):235-43. PubMed ID: 6172012
[TBL] [Abstract][Full Text] [Related]
4. Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma.
George DH; Scheithauer BW; Kovacs K; Horvath E; Young WF; Lloyd RV; Meyer FB
Am J Surg Pathol; 2003 Oct; 27(10):1330-6. PubMed ID: 14508394
[TBL] [Abstract][Full Text] [Related]
5. Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility.
Oldfield EH; Vance ML; Louis RG; Pledger CL; Jane JA; Lopes MB
J Clin Endocrinol Metab; 2015 Aug; 100(8):3165-71. PubMed ID: 26147609
[TBL] [Abstract][Full Text] [Related]
6. Pituitary corticotroph adenoma with crooke's hyalinization.
Franscella S; Favrod-Coune CA; Pizzolato G; Asa SL; Gaillard R; Berney J; Philippe J
Endocr Pathol; 1991 Jun; 2(2):111-116. PubMed ID: 32357610
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical characteristics of Crooke's cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review.
Zhu D; Wang Z; Tian T; Wu X; He D; Zhu Y; Liu D; Wang H
Front Endocrinol (Lausanne); 2022; 13():947085. PubMed ID: 36060980
[TBL] [Abstract][Full Text] [Related]
8. Silent Crooke's cell corticotroph adenoma of the pituitary gland presenting as delayed puberty.
Giri D; Roncaroli F; Sinha A; Didi M; Senniappan S
Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28458905
[TBL] [Abstract][Full Text] [Related]
9. Crooke's cell tumors of the pituitary.
Di Ieva A; Davidson JM; Syro LV; Rotondo F; Montoya JF; Horvath E; Cusimano MD; Kovacs K
Neurosurgery; 2015 May; 76(5):616-22. PubMed ID: 25635886
[TBL] [Abstract][Full Text] [Related]
10. The role of Crooke's changes in recurrence and remission after gamma knife radiosurgery.
Cordeiro D; Xu Z; Nasser M; Lopes B; Vance ML; Sheehan J
J Neurooncol; 2019 Mar; 142(1):171-181. PubMed ID: 30607704
[TBL] [Abstract][Full Text] [Related]
11. Corticotroph pituitary carcinoma: case report and literature review.
Holthouse DJ; Robbins PD; Kahler R; Knuckey N; Pullan P
Endocr Pathol; 2001; 12(3):329-41. PubMed ID: 11740054
[TBL] [Abstract][Full Text] [Related]
12. An ACTH and FSH producing invasive pituitary adenoma with Crooke's hyalinization.
Kamijo K; Sato M; Saito T; Yachi A; Minase T; Noro H; Kawahara T
Pathol Res Pract; 1991 Jun; 187(5):637-41. PubMed ID: 1717963
[TBL] [Abstract][Full Text] [Related]
13. In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas.
Stefaneanu L; Kovacs K; Horvath E; Lloyd RV
Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):107-13. PubMed ID: 1651583
[TBL] [Abstract][Full Text] [Related]
14. Presence of galanin-like immunoreactivity in nontumorous corticotrophs and corticotroph adenomas of the human pituitary.
Vrontakis ME; Sano T; Kovacs K; Friesen HG
J Clin Endocrinol Metab; 1990 Mar; 70(3):747-51. PubMed ID: 1689739
[TBL] [Abstract][Full Text] [Related]
15. Silent corticotroph adenomas: further clinical and pathological observations.
Lopez JA; Kleinschmidt-Demasters Bk Bk; Sze CI; Woodmansee WW; Lillehei KO
Hum Pathol; 2004 Sep; 35(9):1137-47. PubMed ID: 15343517
[TBL] [Abstract][Full Text] [Related]
16. Identification of corticotrophs in the human pituitary with mAB lu-5, a novel immunocytochemical marker.
Kovacs K; Ryan N; Stefaneanu L
Pathol Res Pract; 1987 Dec; 182(6):775-9. PubMed ID: 2449679
[TBL] [Abstract][Full Text] [Related]
17. Histopathology of the pituitary.
Doniach I
Clin Endocrinol Metab; 1985 Nov; 14(4):765-89. PubMed ID: 3002676
[TBL] [Abstract][Full Text] [Related]
18. Successful reduction of ACTH secretion in a case of intractable Cushing's disease with pituitary Crooke's cell adenoma by combined modality therapy including temozolomide.
Tanaka S; Yamamoto M; Morita M; Takeno A; Kanazawa I; Yamaguchi T; Yamada S; Inoshita N; Oki Y; Kurosaki M; Sugimoto T
Endocr J; 2019 Aug; 66(8):701-708. PubMed ID: 31130573
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin immunoreactivity in corticotrophs following glucocorticoid treatment and in pituitary adenomas.
Marin F; Cheng Z; Kovacs K
Arch Pathol Lab Med; 1993 Mar; 117(3):254-8. PubMed ID: 8382913
[TBL] [Abstract][Full Text] [Related]
20. Prognostic indicators in an aggressive pituitary Crooke's cell adenoma.
Kovacs K; Diep CC; Horvath E; Cusimano M; Smyth H; Lombardero CC; Scheithauer BW; Lloyd RV
Can J Neurol Sci; 2005 Nov; 32(4):540-5. PubMed ID: 16408589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
